Načítá se...
The challenge of Helicobacter pylori resistance to antibiotics: the comeback of bismuth-based quadruple therapy
A proton-pump inhibitor (PPI), clarithromycin-based, triple therapy has been the recommended treatment for Helicobacter pylori eradication for the past 15 years. Due to a steady increase in H. pylori resistance to clarithromycin, this triple clarithromycin-based treatment has become progressively le...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3296089/ https://ncbi.nlm.nih.gov/pubmed/22423259 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756283X11432492 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|